2024-07-06 |
Delayed diagnosis of tuberous sclerosis complex: Unveiling low-level TSC2 mosaicism using targeted next-generation sequencing |
Clinical and Experimental Dermatology. 2024 Jul 06;Article in Press. |
|
2024-06-19 |
CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity |
Cell Death and Disease. 2024 Jun 19;15(6):Article number 434. |
|
2024-04 |
Surgical excision and radiotherapy for brain metastasis from colorectal cancer: How frailty and comorbidity indices influence outcome |
Kaohsiung Journal of Medical Sciences. 2024 Apr;40(4):395-403. |
|
2024-01-30 |
Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity |
Cell Death and Disease. 2024 Jan 30;15:Article number 103. |
|
2023-07-31 |
Role of SH3GLB1 in the regulation of CD133 expression in GBM cells |
BMC Cancer. 2023 Jul 31;23:Article number 713. |
|
2023-07-22 |
The complex role of eicosanoids in the brain: Implications for brain tumor development and therapeutic opportunities |
Biochimica et Biophysica Acta. Reviews on Cancer. 2023 Jul 22;1878(5):Article number 188957. |
|
2023-05-30 |
A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment |
American Journal of Cancer Research. 2023 May 30;13(5):1952-1969. |
|
2022-07-13 |
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma |
Journal of Experimental and Clinical Cancer Research. 2022 Jul 13;41:Article number 220. |
|
2022-03-25 |
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation |
Journal of Biomedical Science. 2022 Mar 25;29:Article number 21. |
|
2022-02-02 |
HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells |
Journal of Experimental and Clinical Cancer Research. 2022 Feb 2;41:Article number 47. |
|
2021-10-19 |
SOD2 enhancement by long-term inhibition of the pi3k pathway confers multi-drug resistance and enhanced tumor-initiating features in head and neck cancer |
International Journal of Molecular Sciences. 2021 Oct 19;22(20):Article number 11260. |
|
2021-09-28 |
Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells |
Cell Death and Disease. 2021 Sep 28;12(10):Article number 884. |
|
2021-06-12 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers |
Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253. |
|
2021-05-14 |
Transferrin modified gsh sensitive hyaluronic acid derivative micelle to deliver hsp90 inhibitors to enhance the therapeutic efficacy of brain cancers |
Cancers. 2021 May 14;13(10):Article number 2375. |
|
2021-05 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer |
Gastric Cancer. 2021 May;24(3):624-639. |
|
2021-05 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.] |
Gastric Cancer. 2021 May;24(3):640-641. |
|
2021-04 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors |
Oncologist. 2021 Apr;26(4):e567-e579. |
|
2021-03-08 |
Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma |
Journal of Biomedical Science. 2021 Mar 8;28:Article number 18. |
|
2021-02-24 |
New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis |
International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252. |
|
2020-10 |
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma |
Neuro-Oncology. 2020 Oct;22(10):1439-1451. |
|
2020-05-30 |
Oleic acid -induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis |
Theranostics. 2020 May 30;10(16):7083-7099. |
|
2019-10-19 |
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets |
Journal of Biomedical Science. 2019 Oct 19;26:Article number 77. |
|
2019-09-03 |
Role of autophagy in therapeutic resistance of glioblastoma |
Journal of Cancer Metastasis and Treatment. 2019 Sep 3;5:Article number 66. |
|
2019-06 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial |
Head and Neck. 2019 Jun;41(6):1703-1712. |
|
2017-11 |
Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma |
Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19. |
|
2017-10 |
Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin |
FASEB Journal. 2017 Oct;31(10):4265-4276. |
|
2017-08-12 |
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase |
Redox Biology. 2017 Aug 12;13:655-664. |
|
2017-05-22 |
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma |
Oncogenesis. 2017 May 22;6(5):Article number e339. |
|
2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy |
Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531. |
|
2016-11-18 |
Suberoylanilide hydroxamic acid represses glioma stem-like cells |
Journal of Biomedical Science. 2016 Nov 18;23:Article number 81. |
|
2016-07-19 |
MicroRNA-17 modulates regulatory T cell function by targeting co-regulators of the foxp3 transcription factor |
Immunity. 2016 Jul 19;45(1):83-93. |
|
2015-09 |
O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma |
International Journal of Cancer. 2015 Sep;137(6):1291-1305. |
|
2015-05 |
Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin beta1/FAK axis |
Oncotarget. 2015 May;6(13):11530-11546. |
|
2015-03 |
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer |
Oral Diseases. 2015 Mar;21(2):207-215. |
|
2014-12-22 |
Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation |
Oncotarget. 2014 Dec 22;6(3):1723-1739. |
|
2014-11 |
The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer |
International Journal of Cancer. 2014 Nov;135(10):2424-2436. |
|
2014-10-24 |
Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5year follow-up |
BMC Cancer. 2014 Oct 24;14:Article number 787. |
|
2014-08 |
AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Tumor Biology. 2014 Aug;35(8):7983-7991. |
|
2014-07 |
Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma |
Tumor Biology. 2014 Jul;35(7):7209-7216. |
|
2014-05-05 |
Tea consumption and risk of head and neck cancer |
PLoS ONE. 2014 May 5;9(5):Article number e96507. |
|
2014-02 |
Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma |
Tumor Biology. 2014 Feb;35(2):1703-1712. |
|
2014-01 |
TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Tumor Biology. 2014 Jan;35(1):179-187. |
|
2013-10 |
Investigating the association between oral hygiene and head and neck cancer |
Oral Oncology. 2013 Oct;49(10):1010-1017. |
|
2013-07 |
Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma |
Journal of the Formosan Medical Association. 2013 Jul;112(7):382-389. |
|
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance |
Journal of Biomedical Science. 2013 Jun 27;20(1):Article number 43. |
|
2013-05 |
Complete microscale profiling of tumor microangiogenesis: A microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization |
Biotechnology Advances. 2013 May;31(3):396-401. |
|
2013-03 |
Uropathogenic Escherichia coli causes cortical tubular necrotic cell death and the release of macrophage migration inhibitory factor |
Cytokine. 2013 Mar;61(3):945-952. |
|
2013-02-01 |
Allergies and risk of head and neck cancer: An original study plus meta-analysis |
PLoS ONE. 2013 Feb 1;8(2):Article number e55138. |
|
2012-07-27 |
Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma |
PLoS ONE. 2012 Jul 27;7(7):Article number e41931. |
|
2011-11-15 |
Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo |
Clinical Cancer Research. 2011 Nov 15;17(22):7116-7126. |
|